Strong momentum for Zur Rose IPO as price is tightened
Zur Rose Group, the Swiss-based online pharmacy, told investors this morning that the pricing for its Sfr252m (€231m) IPO was likely to come in the top quarter of the range, thanks to very strong momentum.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts